国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Saccharomyces cerevisiae Glyoxylate reductase 1 (GOR1) CSB-YP346891SVG
CSB-EP346891SVG
CSB-BP346891SVG
CSB-MP346891SVG
CSB-EP346891SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Protein transport protein DSL1 (DSL1), partial CSB-YP346892SVG
CSB-EP346892SVG
CSB-BP346892SVG
CSB-MP346892SVG
CSB-EP346892SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae J protein JJJ1 (JJJ1), partial CSB-YP346893SVG
CSB-EP346893SVG
CSB-BP346893SVG
CSB-MP346893SVG
CSB-EP346893SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uncharacterized protein YNL190W (YNL190W) CSB-YP346894SVG
CSB-EP346894SVG
CSB-BP346894SVG
CSB-MP346894SVG
CSB-EP346894SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Signal transduction protein MDG1 (MDG1) CSB-YP346895SVG
CSB-EP346895SVG
CSB-BP346895SVG
CSB-MP346895SVG
CSB-EP346895SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Ingression protein 1 (INN1) CSB-YP346896SVG
CSB-EP346896SVG
CSB-BP346896SVG
CSB-MP346896SVG
CSB-EP346896SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uncharacterized vacuolar membrane protein YNL115C (YNL115C), partial CSB-YP346897SVG1
CSB-EP346897SVG1
CSB-BP346897SVG1
CSB-MP346897SVG1
CSB-EP346897SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Stress response protein NST1 (NST1), partial CSB-YP346898SVG
CSB-EP346898SVG
CSB-BP346898SVG
CSB-MP346898SVG
CSB-EP346898SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae J domain-containing protein APJ1 (APJ1), partial CSB-YP346899SVG
CSB-EP346899SVG
CSB-BP346899SVG
CSB-MP346899SVG
CSB-EP346899SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uncharacterized endoplasmic reticulum membrane protein YNL046W (YNL046W), partial CSB-YP346900SVG1
CSB-EP346900SVG1
CSB-BP346900SVG1
CSB-MP346900SVG1
CSB-EP346900SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uncharacterized WD repeat-containing protein YNL035C (YNL035C) CSB-YP346901SVG
CSB-EP346901SVG
CSB-BP346901SVG
CSB-MP346901SVG
CSB-EP346901SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Elongation factor 3B (HEF3), partial CSB-YP346902SVG
CSB-EP346902SVG
CSB-BP346902SVG
CSB-MP346902SVG
CSB-EP346902SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Achlya ambisexualis UPF0202 protein CSB-YP346903ABE
CSB-EP346903ABE
CSB-BP346903ABE
CSB-MP346903ABE
CSB-EP346903ABE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii 50S ribosomal protein L3P (rpl3p) CSB-YP346904MRU
CSB-EP346904MRU
CSB-BP346904MRU
CSB-MP346904MRU
CSB-EP346904MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii 50S ribosomal protein L18e (rpl18e) CSB-YP346905MRU
CSB-EP346905MRU
CSB-BP346905MRU
CSB-MP346905MRU
CSB-EP346905MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii 50S ribosomal protein L41e (rpl41e) CSB-YP346906MRU
CSB-EP346906MRU
CSB-BP346906MRU
CSB-MP346906MRU
CSB-EP346906MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii 50S ribosomal protein L11P (rpl11p) CSB-YP346907MRU
CSB-EP346907MRU
CSB-BP346907MRU
CSB-MP346907MRU
CSB-EP346907MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii 30S ribosomal protein S3P (rps3p) CSB-YP346908MRU
CSB-EP346908MRU
CSB-BP346908MRU
CSB-MP346908MRU
CSB-EP346908MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii 50S ribosomal protein L15P (rpl15p) CSB-YP346909MRU
CSB-EP346909MRU
CSB-BP346909MRU
CSB-MP346909MRU
CSB-EP346909MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii 50S ribosomal protein LX (rplX) CSB-YP346910MRU
CSB-EP346910MRU
CSB-BP346910MRU
CSB-MP346910MRU
CSB-EP346910MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>